Correlation Between Novartis and Bayer AG
Can any of the company-specific risk be diversified away by investing in both Novartis and Bayer AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Bayer AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and Bayer AG, you can compare the effects of market volatilities on Novartis and Bayer AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Bayer AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Bayer AG.
Diversification Opportunities for Novartis and Bayer AG
Almost no diversification
The 3 months correlation between Novartis and Bayer is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and Bayer AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bayer AG and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with Bayer AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bayer AG has no effect on the direction of Novartis i.e., Novartis and Bayer AG go up and down completely randomly.
Pair Corralation between Novartis and Bayer AG
Considering the 90-day investment horizon Novartis is expected to generate 1.33 times less return on investment than Bayer AG. But when comparing it to its historical volatility, Novartis AG ADR is 1.82 times less risky than Bayer AG. It trades about 0.22 of its potential returns per unit of risk. Bayer AG is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 1,975 in Bayer AG on December 29, 2024 and sell it today you would earn a total of 476.00 from holding Bayer AG or generate 24.1% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Novartis AG ADR vs. Bayer AG
Performance |
Timeline |
Novartis AG ADR |
Bayer AG |
Novartis and Bayer AG Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novartis and Bayer AG
The main advantage of trading using opposite Novartis and Bayer AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Bayer AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bayer AG will offset losses from the drop in Bayer AG's long position.Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
Bayer AG vs. Fidus Investment Corp | Bayer AG vs. NetSol Technologies | Bayer AG vs. AG Mortgage Investment | Bayer AG vs. Goosehead Insurance |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
CEOs Directory Screen CEOs from public companies around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |